Robert J Salmond

8PUBLICATIONS
16CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 17, 2024
Natural killer cells are required for the recruitment of CD8+ T cells and the efficacy of immune checkpoint blockade in melanoma brain metastases.

Christopher Fife, Jennifer Williams, Fiona James

|Jul 23, 2024
Regulation of T Cell Signaling and Immune Responses by PTPN22.

Rebecca J Brownlie, Robert J Salmond

|Dec 06, 2023
Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion.

Alexandra Rose Teagle, Patricia Castro-Sanchez, Rebecca J Brownlie

|Oct 12, 2021
The Role of Non-essential Amino Acids in T Cell Function and Anti-tumour Immunity.

Helen Carrasco Hope, Robert J Salmond

|Mar 12, 2021
Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model.

Tereza Andreou, Jennifer Williams, Rebecca J Brownlie

|Jul 05, 2019
Targeting the tumor microenvironment and T cell metabolism for effective cancer immunotherapy.

Helen Carrasco Hope, Robert J Salmond

Pageof 2